Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01414400 · ClinicalTrials.gov registry record · NA
Prospective Study to Investigate the Frequency of Possible Bacterial Entry Into the Bloodstream (Bacteremia) and Infectious Complications Associated With the Use of the Spyglass Cholangioscopy System During ERCP (Endoscopic Retrograde Cholangiopancreatography).
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT01414400: Completed NA study, sponsored by Stanford University.
NCT01414400 is a NA study that has completed, run by Stanford University. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01414400, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
The aim of this study is to prospectively evaluate the frequency of bacteremia after ERCP/cholangioscopy using the Spyglass Direct Visualization System. In addition, the frequency of cholangitis/sepsis despite use of post procedural antibiotics will be studied.
Interventions
- OTHER Blood draw for culture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2011-08 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01414400
The ClinicalTrials.gov registry entry for NCT01414400 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood draw for culture is the first listed.
NCT01414400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01414400 about?
NCT01414400 is a clinical study titled "Prospective Study to Investigate the Frequency of Possible Bacterial Entry Into the Bloodstream (Bacteremia) and Infectious Complications Associated With the Use of the Spyglass Cholangioscopy System During ERCP (Endoscopic Retrograde Cholangiopancreatography).". The aim of this study is to prospectively evaluate the frequency of bacteremia after ERCP/cholangioscopy using the Spyglass Direct Visualization System. In addition, the frequency of cholangitis/sepsis despite use of post procedural antibiotics will be studied.
What is the current status of trial NCT01414400?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2011-08. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01414400?
The interventions under investigation include: Blood draw for culture (OTHER).
Who is sponsoring clinical trial NCT01414400?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.